Clinicopathological features of and neoadjuvant therapy for HER2-positive classic invasive lobular carcinoma.
Sign Up to like & getrecommendations! Published in 2021 at "Human pathology"
DOI: 10.1016/j.humpath.2021.07.010
Abstract: Human epidermal growth factor receptor 2 (HER2)-positive classic invasive lobular carcinoma (ILC) is a rare entity, and its specific pathological characteristics and clinical behavior are unclear. Therefore, we retrospectively investigated the clinicopathological features of HER2-positive… read more here.
Keywords: carcinoma; her2 positive; clinicopathological features; positive classic ... See more keywords